Merck to Continue Mesothelioma Clinical Trials Testing Vorinostat
Asbestos.Net News
The trial, known as VANTAGE-14, has enrolled more than half of the necessary patients, and is currently recruiting mesothelioma patients who are being

::: Merck to Continue Mesothelioma Clinical Trials Testing Vorinostat – Asbestos.Net News